-
1
-
-
77952365008
-
Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis
-
Van Deun A, Maug AK, Salim MA, Das PK, Sarker MR, Daru P, Rieder HL. 2010. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 182: 684-692. http://dx.doi.org/10.1164/rccm.201001-0077OC.
-
(2010)
Am. J. Respir. Crit. Care Med.
, vol.182
, pp. 684-692
-
-
Van Deun, A.1
Maug, A.K.2
Salim, M.A.3
Das, P.K.4
Sarker, M.R.5
Daru, P.6
Rieder, H.L.7
-
2
-
-
79953218013
-
Reduction of clofazimine by mycobacterial type 2 nadh: Quinone oxidoreductase: A pathway for the generation of bactericidal levels of reactive oxygen species
-
Yano T, Kassovska-Bratinova S, Teh JS, Winkler J, Sullivan K, Isaacs A, Schechter NM, Rubin H. 2011. Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J. Biol. Chem. 286:10276-10287. http://dx.doi.org/10.1074/jbc.M110.200501.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 10276-10287
-
-
Yano, T.1
Kassovska-Bratinova, S.2
Teh, J.S.3
Winkler, J.4
Sullivan, K.5
Isaacs, A.6
Schechter, N.M.7
Rubin, H.8
-
3
-
-
0035992072
-
Resazurin microtiter assay plate: Simple and inexpensive method for detection of drug resistance in mycobacterium tuberculosis
-
Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. 2002. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46:2720-2722. http://dx.doi.org/10.1128/AAC.46.8.2720-2722.2002.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 2720-2722
-
-
Palomino, J.C.1
Martin, A.2
Camacho, M.3
Guerra, H.4
Swings, J.5
Portaels, F.6
-
4
-
-
84867067622
-
Towards a new tuberculosis drug: Pyridomycin nature's isoniazid
-
Hartkoorn RC, Sala C, Neres J, Pojer F, Magnet S, Mukherjee R, Uplekar S, Boy-Rottger S, Altmann KH, Cole ST. 2012. Towards a new tuberculosis drug: pyridomycin-nature's isoniazid. EMBO Mol. Med. 4:1032-1042. http://dx.doi.org/ 10.1002/emmm.201201689.
-
(2012)
EMBO Mol. Med.
, vol.4
, pp. 1032-1042
-
-
Hartkoorn, R.C.1
Sala, C.2
Neres, J.3
Pojer, F.4
Magnet, S.5
Mukherjee, R.6
Uplekar, S.7
Boy-Rottger, S.8
Altmann, K.H.9
Cole, S.T.10
-
5
-
-
58149114923
-
Azole resistance in mycobacterium tuberculosis is mediated by the mmps5-mmpl5 efflux system
-
Milano A, Pasca MR, Provvedi R, Lucarelli AP, Manina G, Ribeiro AL, Manganelli R, Riccardi G. 2009. Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system. Tuberculosis (Edinb.) 89:84-90. http://dx.doi.org/10.1016/j.tube.2008.08.003.
-
(2009)
Tuberculosis (Edinb.
, vol.89
, pp. 84-90
-
-
Milano, A.1
Pasca, M.R.2
Provvedi, R.3
Lucarelli, A.P.4
Manina, G.5
Ribeiro, A.L.6
Manganelli, R.7
Riccardi, G.8
-
6
-
-
0032708648
-
Analysis of the proteome of mycobacterium tuberculosis in silico
-
Tekaia F, Gordon SV, Garnier T, Brosch R, Barrell BG, Cole ST. 1999. Analysis of the proteome of Mycobacterium tuberculosis in silico. Tuber. Lung Dis. 79:329-342. http://dx.doi.org/10.1054/tuld.1999.0220.
-
(1999)
Tuber. Lung Dis.
, vol.79
, pp. 329-342
-
-
Tekaia, F.1
Gordon, S.V.2
Garnier, T.3
Brosch, R.4
Barrell, B.G.5
Cole, S.T.6
-
7
-
-
19744376797
-
Contribution of the mycobacterium tuberculosis mmpl protein family to virulence and drug resistance
-
Domenech P, Reed MB, Barry CE. 2005. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect. Immun. 73:3492-3501. http://dx.doi.org/10.1128/IAI.73.6.3492-3501.2005.
-
(2005)
Infect. Immun.
, vol.73
, pp. 3492-3501
-
-
Domenech, P.1
Reed, M.B.2
Barry, C.E.3
-
8
-
-
84875073345
-
Discovery of a siderophore export system essential for virulence of mycobacterium tuberculosis
-
Wells RM, Jones CM, Xi Z, Speer A, Danilchanka O, Doornbos KS, Sun P, Wu F, Tian C, Niederweis M. 2013. Discovery of a siderophore export system essential for virulence of Mycobacterium tuberculosis. PLoS Pathog. 9:e1003120. http://dx.doi.org/10.1371/journal.ppat.1003120.
-
(2013)
PLoS Pathog.
, vol.9
-
-
Wells, R.M.1
Jones, C.M.2
Xi, Z.3
Speer, A.4
Danilchanka, O.5
Doornbos, K.S.6
Sun, P.7
Wu, F.8
Tian, C.9
Niederweis, M.10
-
9
-
-
84893468680
-
Self-poisoning of mycobacterium tuberculosis by interrupting siderophore recycling
-
Jones CM, Wells RM, Madduri AV, Renfrow MB, Ratledge C, Moody DB, Niederweis M. 2014. Self-poisoning of Mycobacterium tuberculosis by interrupting siderophore recycling. Proc. Natl. Acad. Sci. U. S. A. 111: 1945-1950. http://dx.doi.org/10.1073/pnas.1311402111.
-
(2014)
Proc. Natl. Acad. Sci. U. S. A.
, vol.111
, pp. 1945-1950
-
-
Jones, C.M.1
Wells, R.M.2
Madduri, A.V.3
Renfrow, M.B.4
Ratledge, C.5
Moody, D.B.6
Niederweis, M.7
-
10
-
-
84891543452
-
Efflux inhibition with verapamil potentiates bedaquiline in mycobacterium tuberculosis
-
Gupta S, Cohen KA, Winglee K, Maiga M, Diarra B, Bishai WR. 2014. Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 58:574-576. http://dx.doi.org/10.1128/AAC.01462- 13.
-
(2014)
Antimicrob. Agents Chemother.
, vol.58
, pp. 574-576
-
-
Gupta, S.1
Cohen, K.A.2
Winglee, K.3
Maiga, M.4
Diarra, B.5
Bishai, W.R.6
-
11
-
-
84861137329
-
Sterilizing activities of novel combinations lacking first-And second-line drugs in a murine model of tuberculosis
-
Williams K, Minkowski A, Amoabeng O, Peloquin CA, Taylor D, Andries K, Wallis RS, Mdluli KE, Nuermberger EL. 2012. Sterilizing activities of novel combinations lacking first-And second-line drugs in a murine model of tuberculosis. Antimicrob. Agents Chemother. 56:3114-3120. http://dx.doi.org/10. 1128/AAC.00384-12.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 3114-3120
-
-
Williams, K.1
Minkowski, A.2
Amoabeng, O.3
Peloquin, C.A.4
Taylor, D.5
Andries, K.6
Wallis, R.S.7
Mdluli, K.E.8
Nuermberger, E.L.9
-
12
-
-
84896716778
-
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
-
5 February 2014
-
Makarov V, Lechartier B, Zhang M, Neres J, van der Sar AM, Raadsen SA, Hartkoorn RC, Ryabova OB, Vocat A, Decosterd LA, Widmer N, Buclin T, Bitter W, Andries K, Pojer F, Dyson PJ, Cole ST. 5 February 2014. Towards a new combination therapy for tuberculosis with next generation benzothiazinones. EMBO Mol. Med. http://dx.doi.org/10.1002/emmm.201303575.
-
EMBO Mol. Med
-
-
Makarov, V.1
Lechartier, B.2
Zhang, M.3
Neres, J.4
Van Der Sar, A.M.5
Raadsen, S.A.6
Hartkoorn, R.C.7
Ryabova, O.B.8
Vocat, A.9
Decosterd, L.A.10
Widmer, N.11
Buclin, T.12
Bitter, W.13
Andries, K.14
Pojer, F.15
Dyson, P.J.16
Cole, S.T.17
-
13
-
-
84868032303
-
In vitro combination studies of benzothiazinone lead compound btz043 against mycobacterium tuberculosis
-
Lechartier B, Hartkoorn RC, Cole ST. 2012. In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56:5790-5793. http://dx.doi.org/10.1128/AAC.01476- 12.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 5790-5793
-
-
Lechartier, B.1
Hartkoorn, R.C.2
Cole, S.T.3
-
14
-
-
84861140844
-
Randomized pilot trial of eight weeks of bedaquiline (tmc207) treatment for multidrugresistant tuberculosis: Long-term outcome, tolerability, and effect on emergence of drug resistance
-
Diacon AH, Donald PR, Pym A, Grobusch M, Patientia RF, Mahanyele R, Bantubani N, Narasimooloo R, De Marez T, van Heeswijk R, Lounis N, Meyvisch P, Andries K, McNeeley DF. 2012. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrugresistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrob. Agents Chemother. 56:3271-3276. http://dx.doi.org/10.1128/AAC.06126-11.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 3271-3276
-
-
Diacon, A.H.1
Donald, P.R.2
Pym, A.3
Grobusch, M.4
Patientia, R.F.5
Mahanyele, R.6
Bantubani, N.7
Narasimooloo, R.8
De Marez, T.9
Van Heeswijk, R.10
Lounis, N.11
Meyvisch, P.12
Andries, K.13
McNeeley, D.F.14
-
15
-
-
19944429772
-
A diarylquinoline drug active on the atp synthase of mycobacterium tuberculosis
-
Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V. 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307:223-227. http://dx.doi.org/10.1126/science.1106753.
-
(2005)
Science
, vol.307
, pp. 223-227
-
-
Andries, K.1
Verhasselt, P.2
Guillemont, J.3
Gohlmann, H.W.4
Neefs, J.M.5
Winkler, H.6
Van Gestel, J.7
Timmerman, P.8
Zhu, M.9
Lee, E.10
Williams, P.11
De Chaffoy, D.12
Huitric, E.13
Hoffner, S.14
Cambau, E.15
Truffot-Pernot, C.16
Lounis, N.17
Jarlier, V.18
-
16
-
-
77149123917
-
Rates and mechanisms of resistance development in mycobacterium tuberculosis to a novel diarylquinoline atp synthase inhibitor
-
Huitric E, Verhasselt P, Koul A, Andries K, Hoffner S, Andersson DI. 2010. Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor. Antimicrob. Agents Chemother. 54:1022-1028. http://dx.doi.org/10.1128/AAC.01611-09.
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 1022-1028
-
-
Huitric, E.1
Verhasselt, P.2
Koul, A.3
Andries, K.4
Hoffner, S.5
Andersson, D.I.6
|